Coletta, D K <br/><br/>
The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  May 2015 
 - 657-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.12664  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--physiology<br/>Adiponectin--blood<br/>Biopsy<br/>Blood Glucose--metabolism<br/>Diabetes Mellitus, Type 2--genetics<br/>Fatty Acids, Nonesterified--metabolism<br/>Female<br/>Glycine--analogs & derivatives<br/>Humans<br/>Insulin--blood<br/>Insulin Resistance--physiology<br/>Male<br/>Middle Aged<br/>Mitochondria, Muscle--drug effects<br/>Muscle, Skeletal--drug effects<br/>Oxazoles--pharmacology<br/>Oxidation-Reduction<br/>PPAR alpha--agonists<br/>PPAR gamma--agonists<br/>Signal Transduction--drug effects<br/>Triglycerides--blood